Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients

200353 citationsJournal Article

Authors

W. Lawrence Drew · Vitalant

Gary E. Tegtmeier · Metropolitan Community College - Kansas City

Harvey J. Alter · University of the Pacific

Megan E. Laycock · National Institutes of Health Clinical Center

Richard C. Miner · University of the Pacific

Michael P. Busch · Kansas City Kansas Community College

Abstract

Plasma CMV DNA was detected in a small percentage of seroconverting blood donors and a larger percentage of recipients but was undetectable in seroprevalent donors. Plasma viremia in seroconverting donors may partially explain the low residual risk of CMV transmission by both CMV-seronegative and WBC-reduced seropositive blood.

Topics & Keywords

Cytomegalovirus and herpesvirus research Herpesvirus Infections and Treatments Parvovirus B19 Infection Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transfusion

Volume 43, Issue 3, pp. 309-313

DOI: 10.1046/j.1537-2995.2003.00337.x

Field-Weighted Citation Impact: 2.54